18,493 Shares in iShares U.S. Pharmaceuticals ETF $IHE Purchased by Lee Johnson Capital Management LLC

Lee Johnson Capital Management LLC bought a new position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 18,493 shares of the company’s stock, valued at approximately $1,603,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of IHE. Corient Private Wealth LLC lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 3.1% in the 4th quarter. Corient Private Wealth LLC now owns 6,506 shares of the company’s stock worth $552,000 after purchasing an additional 198 shares during the last quarter. Axxcess Wealth Management LLC grew its stake in iShares U.S. Pharmaceuticals ETF by 27.7% during the 4th quarter. Axxcess Wealth Management LLC now owns 9,062 shares of the company’s stock worth $769,000 after buying an additional 1,968 shares during the last quarter. Beacon Pointe Advisors LLC grew its stake in iShares U.S. Pharmaceuticals ETF by 50.4% during the 4th quarter. Beacon Pointe Advisors LLC now owns 26,621 shares of the company’s stock worth $2,258,000 after buying an additional 8,921 shares during the last quarter. VestGen Advisors LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF in the fourth quarter worth $1,998,000. Finally, EFG International AG acquired a new stake in iShares U.S. Pharmaceuticals ETF in the fourth quarter worth $38,000.

iShares U.S. Pharmaceuticals ETF Stock Performance

IHE stock opened at $91.88 on Monday. iShares U.S. Pharmaceuticals ETF has a 1 year low of $64.46 and a 1 year high of $95.60. The stock has a market capitalization of $992.30 million, a price-to-earnings ratio of 17.75 and a beta of 0.50. The stock’s fifty day moving average is $89.67 and its two-hundred day moving average is $87.79.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.